diazooxonorleucine has been researched along with Granulocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzgerald, M; Keast, D | 1 |
| Crawford, M; Griffiths, M; Keast, D; Palmer, TN; Patrick, G | 1 |
2 other study(ies) available for diazooxonorleucine and Granulocytic Leukemia
| Article | Year |
|---|---|
Fab fragments from the monoclonal antibody ML30 bind to treated human myeloid leukemia cells.
Topics: Animals; Antibodies, Monoclonal; Bacterial Proteins; Diazooxonorleucine; Heat-Shock Proteins; Humans; Immunoglobulin Fab Fragments; Leukemia, Myeloid; Mice; Mycobacterium; Tumor Cells, Cultured | 1994 |
The role of glutamine and glucose analogues in metabolic inhibition of human myeloid leukaemia in vitro.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Deoxyglucose; Diazooxonorleucine; Humans; Isoxazoles; Leukemia, Myeloid; Tumor Cells, Cultured | 1993 |